Sanctuary Advisors LLC Acquires 6,359 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sanctuary Advisors LLC grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,609 shares of the medical device company’s stock after acquiring an additional 6,359 shares during the period. Sanctuary Advisors LLC’s holdings in Cooper Companies were worth $4,093,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the stock. Point72 Asset Management L.P. lifted its stake in Cooper Companies by 480.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock worth $81,870,000 after purchasing an additional 776,140 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after buying an additional 737,726 shares in the last quarter. Magnetar Financial LLC purchased a new stake in shares of Cooper Companies in the second quarter worth $63,822,000. TD Asset Management Inc bought a new stake in Cooper Companies during the second quarter valued at $53,045,000. Finally, Impax Asset Management Group plc grew its position in Cooper Companies by 31.0% during the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after buying an additional 558,886 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 0.9 %

Shares of NASDAQ:COO opened at $93.98 on Tuesday. The stock’s 50-day moving average is $103.26 and its 200 day moving average is $99.00. The company has a market cap of $18.76 billion, a PE ratio of 48.19, a P/E/G ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.87 earnings per share. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

COO has been the topic of several recent analyst reports. Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Wells Fargo & Company lifted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Insider Transactions at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.